Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Completed
CT.gov ID
NCT00269373
Collaborator
(none)
136
1
74
1.8

Study Details

Study Description

Brief Summary

Is PET-CT scan better than PET or CT alone in diagnosing primary tumours in patients with unknown primary tumors? Can information obtained with PET-CT replace other clinical and radiological investigations? Is PET/CT cost-effective?

Condition or Disease Intervention/Treatment Phase
  • Procedure: PET-CT

Detailed Description

Patients who fulfill the international definition of unknown primary tumors can be included, except:

  • Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.

  • Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included.

  • Women with adenocarcinoma in lymph nodes in the axilla will not be included.

Study Design

Study Type:
Observational
Actual Enrollment :
136 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors
Study Start Date :
Dec 1, 2005
Actual Primary Completion Date :
Feb 1, 2012
Actual Study Completion Date :
Feb 1, 2012

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Unknown primary tumors
    Exclusion Criteria:
    • Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.

    • Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included

    • Women with adenocarcinoma in lymph nodes in the axilla will not be included

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Rigshospitalet Copenhagen Denmark 2100

    Sponsors and Collaborators

    • Rigshospitalet, Denmark

    Investigators

    • Principal Investigator: Gedske Daugaard, Rigshospitalet, Denmark

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gedske Daugaard, Associate professor, Rigshospitalet, Denmark
    ClinicalTrials.gov Identifier:
    NCT00269373
    Other Study ID Numbers:
    • 01 283694
    First Posted:
    Dec 23, 2005
    Last Update Posted:
    Feb 22, 2012
    Last Verified:
    Feb 1, 2012
    Keywords provided by Gedske Daugaard, Associate professor, Rigshospitalet, Denmark
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 22, 2012